09: The MedTech Venture Builder Experience: From Innovation to Impact
Bringing MedTech innovation to market requires more than a working device—it’s about timing and successfully navigating the journey to commercial success.
Register now for our Application Information Session!
Are you a high-potential MedTech innovator looking to accelerate your journey from concept to investment-ready venture? The MedTech Venture Builder is a unique 12-month structured programme designed to fast-track the commercial translation of groundbreaking medical technologies.
Now in its second year, the MedTech Venture Builder provides a comprehensive framework to de-risk your company, including regulatory planning, clinical evidence roadmaps, stakeholder mapping, and hands-on expert support—all within a fit-for-purpose Quality Management System (QMS).
Join us for an in-person Application Info Session on Wednesday 26 March to gain a deeper understanding of how the MedTech Venture Builder programme can support your venture.
Through expert mentorship, hands-on guidance, and real-world industry connections, the MedTech Venture Builder, delivered by LIHE, helps innovators turn promising ideas into market-ready ventures.
Thomas Vargoczky, CEO of Pryfiber, a spinout from Queen Mary University of London, and a member of our ongoing MVB cohort shares his experience of the programme:
The MedTech Venture Builder is funded by Research England and is a collaborative effort between London’s leading academic institutions, King's College London (lead), Queen Mary University of London, and City St George’s, University of London.